Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peptidylprolyl Isomerase | 24 | 2020 | 97 | 3.110 |
Why?
|
Breast Neoplasms | 38 | 2024 | 21207 | 1.200 |
Why?
|
Breast | 7 | 2024 | 1976 | 0.940 |
Why?
|
Poly(ADP-ribose) Polymerases | 3 | 2024 | 428 | 0.910 |
Why?
|
BRCA1 Protein | 10 | 2022 | 1155 | 0.880 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2016 | 2846 | 0.870 |
Why?
|
Infectious Mononucleosis | 2 | 2022 | 133 | 0.860 |
Why?
|
Phthalazines | 7 | 2022 | 397 | 0.770 |
Why?
|
Mammary Neoplasms, Experimental | 6 | 2024 | 506 | 0.730 |
Why?
|
Phosphatidylinositol 3-Kinases | 9 | 2024 | 2885 | 0.680 |
Why?
|
Ovarian Neoplasms | 6 | 2022 | 4916 | 0.640 |
Why?
|
Genes, BRCA1 | 3 | 2023 | 755 | 0.630 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2020 | 480 | 0.610 |
Why?
|
Testosterone | 4 | 2024 | 2491 | 0.610 |
Why?
|
Gene Fusion | 2 | 2019 | 356 | 0.580 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 17 | 2024 | 11878 | 0.570 |
Why?
|
Fructose-Bisphosphate Aldolase | 2 | 2020 | 43 | 0.570 |
Why?
|
Ketones | 3 | 2024 | 183 | 0.550 |
Why?
|
Furans | 3 | 2024 | 202 | 0.550 |
Why?
|
Ubiquitin | 2 | 2020 | 843 | 0.530 |
Why?
|
Nucleosides | 1 | 2016 | 130 | 0.510 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.500 |
Why?
|
Herpesvirus 4, Human | 2 | 2022 | 1082 | 0.480 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5341 | 0.470 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2017 | 2956 | 0.460 |
Why?
|
Mammary Glands, Animal | 4 | 2017 | 273 | 0.450 |
Why?
|
DNA Damage | 5 | 2020 | 2469 | 0.440 |
Why?
|
Mammography | 1 | 2024 | 2433 | 0.430 |
Why?
|
Receptor, erbB-2 | 9 | 2021 | 2603 | 0.410 |
Why?
|
Neoplasms | 8 | 2025 | 22371 | 0.400 |
Why?
|
BRCA2 Protein | 4 | 2022 | 802 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2019 | 2459 | 0.370 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 17142 | 0.360 |
Why?
|
Morpholines | 3 | 2019 | 584 | 0.350 |
Why?
|
Interleukin-8 | 1 | 2013 | 705 | 0.340 |
Why?
|
Aminopyridines | 3 | 2019 | 580 | 0.330 |
Why?
|
Piperazines | 5 | 2022 | 2554 | 0.330 |
Why?
|
Epithelial Cells | 5 | 2016 | 3703 | 0.310 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4120 | 0.300 |
Why?
|
Mutation | 13 | 2024 | 30237 | 0.290 |
Why?
|
Signal Transduction | 20 | 2024 | 23648 | 0.290 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2024 | 3612 | 0.270 |
Why?
|
Cyclin D1 | 4 | 2004 | 453 | 0.270 |
Why?
|
Methionine Adenosyltransferase | 1 | 2025 | 16 | 0.250 |
Why?
|
Maximum Tolerated Dose | 2 | 2025 | 899 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5704 | 0.230 |
Why?
|
Mice, SCID | 4 | 2021 | 2627 | 0.230 |
Why?
|
Mice | 31 | 2024 | 82049 | 0.230 |
Why?
|
Pyruvic Acid | 2 | 2022 | 205 | 0.220 |
Why?
|
Sex Reassignment Procedures | 1 | 2024 | 72 | 0.220 |
Why?
|
Female | 58 | 2025 | 397187 | 0.220 |
Why?
|
Mitosis | 6 | 2024 | 1178 | 0.210 |
Why?
|
Pentose Phosphate Pathway | 2 | 2021 | 126 | 0.210 |
Why?
|
Humans | 84 | 2025 | 768171 | 0.210 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2016 | 434 | 0.200 |
Why?
|
Receptors, Estrogen | 6 | 2023 | 2253 | 0.200 |
Why?
|
Animals | 39 | 2024 | 169285 | 0.200 |
Why?
|
Cell Division | 2 | 2009 | 4477 | 0.190 |
Why?
|
Cell Cycle | 5 | 2024 | 2934 | 0.190 |
Why?
|
Mice, Inbred NOD | 2 | 2016 | 1837 | 0.190 |
Why?
|
Phosphorylation | 14 | 2024 | 8316 | 0.190 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 422 | 0.190 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2021 | 22 | 0.190 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1901 | 0.190 |
Why?
|
Nipples | 1 | 2023 | 227 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2020 | 8648 | 0.180 |
Why?
|
Gene Deletion | 3 | 2021 | 2674 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2001 | 287 | 0.180 |
Why?
|
Cell Differentiation | 7 | 2021 | 11677 | 0.180 |
Why?
|
Ear | 1 | 2001 | 172 | 0.180 |
Why?
|
Cell Cycle Proteins | 3 | 2024 | 3445 | 0.170 |
Why?
|
Niacinamide | 1 | 2022 | 418 | 0.170 |
Why?
|
Cyclins | 1 | 2002 | 606 | 0.170 |
Why?
|
Retinal Dehydrogenase | 2 | 2011 | 78 | 0.170 |
Why?
|
Vincristine | 5 | 2020 | 1040 | 0.170 |
Why?
|
Transcriptional Activation | 4 | 2015 | 1750 | 0.170 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2023 | 481 | 0.170 |
Why?
|
Cells, Cultured | 9 | 2020 | 19025 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 905 | 0.160 |
Why?
|
Reactive Oxygen Species | 3 | 2022 | 2152 | 0.160 |
Why?
|
Mice, Knockout | 11 | 2021 | 14488 | 0.160 |
Why?
|
Immunohistochemistry | 7 | 2019 | 11095 | 0.160 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2020 | 246 | 0.160 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 6124 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2020 | 998 | 0.150 |
Why?
|
Prothrombin | 1 | 1999 | 194 | 0.150 |
Why?
|
NAD | 1 | 2022 | 618 | 0.150 |
Why?
|
Factor V | 1 | 1999 | 168 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4648 | 0.150 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2020 | 414 | 0.150 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.150 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2019 | 432 | 0.150 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6847 | 0.150 |
Why?
|
Isoenzymes | 3 | 2013 | 1688 | 0.140 |
Why?
|
Breast Diseases | 1 | 2020 | 442 | 0.140 |
Why?
|
Protons | 1 | 2022 | 1113 | 0.140 |
Why?
|
RNA Interference | 3 | 2016 | 2832 | 0.140 |
Why?
|
3' Untranslated Regions | 1 | 1999 | 515 | 0.140 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2019 | 296 | 0.130 |
Why?
|
Cell Proliferation | 6 | 2024 | 10478 | 0.130 |
Why?
|
Mammary Glands, Human | 1 | 2017 | 202 | 0.130 |
Why?
|
Carboplatin | 1 | 2019 | 797 | 0.130 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 117 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 410 | 0.130 |
Why?
|
Macrophages | 2 | 2022 | 5802 | 0.130 |
Why?
|
Glycolysis | 2 | 2020 | 837 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1062 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9540 | 0.130 |
Why?
|
Antineoplastic Agents | 6 | 2025 | 13677 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1009 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2016 | 126 | 0.130 |
Why?
|
Sirolimus | 3 | 2016 | 1540 | 0.120 |
Why?
|
Thiazoles | 2 | 2022 | 1542 | 0.120 |
Why?
|
MAP Kinase Signaling System | 3 | 2020 | 1495 | 0.120 |
Why?
|
Adult | 24 | 2025 | 223646 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2019 | 2982 | 0.120 |
Why?
|
Microtubules | 2 | 2020 | 1064 | 0.120 |
Why?
|
Viral Matrix Proteins | 1 | 2016 | 193 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3806 | 0.120 |
Why?
|
Catalysis | 3 | 2006 | 768 | 0.120 |
Why?
|
Cytomegalovirus | 1 | 2019 | 753 | 0.120 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 952 | 0.120 |
Why?
|
Centrosome | 2 | 2006 | 210 | 0.120 |
Why?
|
Protein Stability | 2 | 2024 | 579 | 0.120 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1756 | 0.120 |
Why?
|
Neoplasm Metastasis | 7 | 2021 | 4913 | 0.120 |
Why?
|
Transcription, Genetic | 5 | 2008 | 7609 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5442 | 0.110 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3428 | 0.110 |
Why?
|
Homozygote | 1 | 1999 | 1779 | 0.110 |
Why?
|
MicroRNAs | 2 | 2024 | 3803 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 757 | 0.110 |
Why?
|
Drug Synergism | 2 | 2021 | 1760 | 0.110 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1744 | 0.110 |
Why?
|
Middle Aged | 23 | 2025 | 223487 | 0.110 |
Why?
|
rab GTP-Binding Proteins | 1 | 2015 | 247 | 0.110 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.110 |
Why?
|
ras Proteins | 3 | 2004 | 1058 | 0.110 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18349 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 322 | 0.100 |
Why?
|
Immunoblotting | 1 | 2016 | 1648 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22380 | 0.100 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1628 | 0.100 |
Why?
|
Cytosol | 1 | 2016 | 887 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1625 | 0.100 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1904 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 489 | 0.100 |
Why?
|
Transplantation, Heterologous | 2 | 2021 | 2393 | 0.100 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 874 | 0.100 |
Why?
|
Pyruvate Kinase | 1 | 2013 | 191 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2001 | 1077 | 0.100 |
Why?
|
Phenotype | 5 | 2022 | 16726 | 0.100 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2011 | 41 | 0.090 |
Why?
|
Quinazolines | 2 | 2024 | 1373 | 0.090 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3948 | 0.090 |
Why?
|
Virus Replication | 1 | 2019 | 2458 | 0.090 |
Why?
|
Epidermal Growth Factor | 2 | 2011 | 697 | 0.090 |
Why?
|
Estradiol | 1 | 2018 | 1951 | 0.090 |
Why?
|
Telomeric Repeat Binding Protein 1 | 2 | 2008 | 7 | 0.090 |
Why?
|
Neoplasm Transplantation | 4 | 2017 | 2014 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3782 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2050 | 0.090 |
Why?
|
Cytoskeleton | 1 | 2016 | 1179 | 0.090 |
Why?
|
beta Catenin | 3 | 2006 | 1047 | 0.090 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2011 | 117 | 0.090 |
Why?
|
RNA, Neoplasm | 2 | 2009 | 749 | 0.090 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 77 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3912 | 0.090 |
Why?
|
Hematopoiesis | 3 | 1994 | 2059 | 0.090 |
Why?
|
Aged | 18 | 2025 | 171502 | 0.090 |
Why?
|
Mice, Nude | 3 | 2021 | 3623 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2830 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1110 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3604 | 0.080 |
Why?
|
Neoplastic Stem Cells | 2 | 2015 | 1351 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2062 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2008 | 1966 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1321 | 0.080 |
Why?
|
DNA, Viral | 1 | 2016 | 2204 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2016 | 2732 | 0.080 |
Why?
|
Telomere | 2 | 2008 | 943 | 0.080 |
Why?
|
Drug Resistance | 2 | 1994 | 1599 | 0.080 |
Why?
|
Survival Rate | 5 | 2021 | 12840 | 0.080 |
Why?
|
DNA-Binding Proteins | 5 | 2009 | 9617 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.080 |
Why?
|
Genes, p53 | 1 | 2011 | 714 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4754 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2025 | 3728 | 0.080 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2009 | 146 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2003 | 1169 | 0.080 |
Why?
|
Amino Acid Motifs | 4 | 2021 | 930 | 0.080 |
Why?
|
Phosphothreonine | 2 | 2005 | 62 | 0.070 |
Why?
|
Germ-Line Mutation | 3 | 2023 | 1885 | 0.070 |
Why?
|
Isomerism | 2 | 2005 | 198 | 0.070 |
Why?
|
Asthenozoospermia | 1 | 2007 | 6 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13290 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 3 | 1994 | 3409 | 0.070 |
Why?
|
Alzheimer Disease | 4 | 2006 | 8759 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2003 | 1327 | 0.070 |
Why?
|
Hodgkin Disease | 3 | 1998 | 1384 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2019 | 3589 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 13053 | 0.070 |
Why?
|
Apoptosis | 5 | 2024 | 9527 | 0.070 |
Why?
|
Receptors, Progesterone | 2 | 2021 | 1160 | 0.060 |
Why?
|
Organoids | 2 | 2023 | 743 | 0.060 |
Why?
|
Membrane Proteins | 3 | 2019 | 7876 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5505 | 0.060 |
Why?
|
Etoposide | 4 | 2019 | 639 | 0.060 |
Why?
|
Androgen Receptor Antagonists | 1 | 2006 | 123 | 0.060 |
Why?
|
Phosphoserine | 1 | 2005 | 204 | 0.060 |
Why?
|
Sexual Abstinence | 1 | 2004 | 17 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1105 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9561 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 1994 | 3713 | 0.050 |
Why?
|
S-Adenosylmethionine | 1 | 2025 | 219 | 0.050 |
Why?
|
Testis | 1 | 2007 | 783 | 0.050 |
Why?
|
Down-Regulation | 2 | 2008 | 2939 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Protein Binding | 7 | 2020 | 9343 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9262 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3626 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1994 | 1642 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2002 | 4528 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2003 | 4939 | 0.050 |
Why?
|
Spermatozoa | 1 | 2007 | 632 | 0.050 |
Why?
|
Trans-Activators | 2 | 2003 | 2857 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 1606 | 0.050 |
Why?
|
Male | 17 | 2025 | 364731 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54924 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 340 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 401 | 0.050 |
Why?
|
Reference Values | 1 | 2009 | 4939 | 0.050 |
Why?
|
6-Aminonicotinamide | 1 | 2021 | 8 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 379 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 293 | 0.050 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2021 | 81 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6610 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 262 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2040 | 0.050 |
Why?
|
Mastectomy | 2 | 2020 | 1862 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 630 | 0.040 |
Why?
|
Doxorubicin | 4 | 2020 | 2234 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 1117 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2023 | 593 | 0.040 |
Why?
|
Adolescent | 6 | 2022 | 89169 | 0.040 |
Why?
|
Molecular Sequence Data | 7 | 2013 | 17623 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9419 | 0.040 |
Why?
|
Alanine | 1 | 2022 | 614 | 0.040 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2001 | 219 | 0.040 |
Why?
|
Gene Expression | 4 | 2006 | 7601 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1151 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 440 | 0.040 |
Why?
|
Granzymes | 1 | 2021 | 277 | 0.040 |
Why?
|
Blood Coagulation Factor Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
|
Phosphatidylinositols | 1 | 2020 | 280 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 60066 | 0.040 |
Why?
|
Idarubicin | 1 | 2019 | 59 | 0.040 |
Why?
|
Taxoids | 1 | 2022 | 667 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10763 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2021 | 246 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.040 |
Why?
|
Treatment Outcome | 9 | 2021 | 65379 | 0.040 |
Why?
|
Fibroblasts | 3 | 2023 | 4178 | 0.040 |
Why?
|
Symporters | 1 | 2021 | 363 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 596 | 0.040 |
Why?
|
Base Sequence | 5 | 2013 | 12422 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 343 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 736 | 0.040 |
Why?
|
Nuclear Family | 1 | 1999 | 311 | 0.040 |
Why?
|
Blood Coagulation Tests | 1 | 1999 | 270 | 0.040 |
Why?
|
Models, Molecular | 3 | 2017 | 5402 | 0.040 |
Why?
|
Nucleotides | 1 | 2020 | 455 | 0.040 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 165 | 0.040 |
Why?
|
Protein Conformation | 1 | 2005 | 3956 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 205 | 0.040 |
Why?
|
Genome, Human | 2 | 2021 | 4446 | 0.030 |
Why?
|
Azacitidine | 1 | 2019 | 336 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 957 | 0.030 |
Why?
|
Thiophenes | 1 | 2021 | 570 | 0.030 |
Why?
|
Protein Structure, Tertiary | 4 | 2006 | 3772 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2021 | 887 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 1998 | 1791 | 0.030 |
Why?
|
Chromosomal Instability | 2 | 2008 | 176 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13586 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 213 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10873 | 0.030 |
Why?
|
Antithrombins | 1 | 1999 | 294 | 0.030 |
Why?
|
Transfection | 4 | 2006 | 5756 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1133 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 2004 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2020 | 622 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1251 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1999 | 519 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2021 | 1165 | 0.030 |
Why?
|
Homocysteine | 1 | 1999 | 637 | 0.030 |
Why?
|
Pyridones | 1 | 2021 | 819 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 938 | 0.030 |
Why?
|
RNA, Messenger | 4 | 1994 | 12801 | 0.030 |
Why?
|
Genomic Instability | 1 | 2020 | 716 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2001 | 788 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1234 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10099 | 0.030 |
Why?
|
Bone Marrow Cells | 2 | 2001 | 2414 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3284 | 0.030 |
Why?
|
NF-kappa B | 1 | 2003 | 2494 | 0.030 |
Why?
|
Data Mining | 1 | 2020 | 563 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36741 | 0.030 |
Why?
|
Estrogens | 1 | 2021 | 1536 | 0.030 |
Why?
|
Procarbazine | 3 | 1998 | 172 | 0.030 |
Why?
|
Phenanthrolines | 1 | 2014 | 49 | 0.030 |
Why?
|
Ascites | 1 | 2016 | 338 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1754 | 0.030 |
Why?
|
Cell Line | 5 | 2011 | 15602 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2016 | 332 | 0.030 |
Why?
|
Equipment Design | 1 | 2022 | 3522 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2107 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 281 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 4 | 2007 | 3740 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2909 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 996 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 1993 | 91 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1660 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2512 | 0.030 |
Why?
|
Child | 1 | 2022 | 80917 | 0.030 |
Why?
|
RNA, Antisense | 1 | 1993 | 136 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 2892 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2002 | 5797 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2001 | 11930 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 224 | 0.030 |
Why?
|
Bleomycin | 3 | 1998 | 493 | 0.030 |
Why?
|
CHO Cells | 2 | 2006 | 1379 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 964 | 0.030 |
Why?
|
Cell Respiration | 1 | 2013 | 201 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 2 | 2011 | 1120 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 705 | 0.030 |
Why?
|
Epithelium | 1 | 2017 | 1607 | 0.030 |
Why?
|
Mutagenesis | 2 | 2013 | 1228 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1505 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2722 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2006 | 3914 | 0.030 |
Why?
|
Cricetinae | 2 | 2006 | 2423 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59626 | 0.020 |
Why?
|
Heterozygote | 1 | 1999 | 2798 | 0.020 |
Why?
|
Prostatic Neoplasms | 2 | 2006 | 11101 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3655 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2020 | 81760 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3556 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1197 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 899 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4149 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 806 | 0.020 |
Why?
|
Metabolome | 1 | 2017 | 1009 | 0.020 |
Why?
|
Warfarin | 1 | 1999 | 1493 | 0.020 |
Why?
|
Cytokines | 2 | 2021 | 7452 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2474 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2006 | 1524 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8743 | 0.020 |
Why?
|
Prednisone | 3 | 1998 | 1567 | 0.020 |
Why?
|
DNA Primers | 1 | 1993 | 2828 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2009 | 33 | 0.020 |
Why?
|
Transcription Factors | 2 | 2002 | 12171 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1904 | 0.020 |
Why?
|
Verapamil | 1 | 1989 | 242 | 0.020 |
Why?
|
RNA Splicing | 1 | 2013 | 905 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1993 | 948 | 0.020 |
Why?
|
tau Proteins | 1 | 1999 | 2144 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11244 | 0.020 |
Why?
|
Cyclophosphamide | 3 | 1998 | 2227 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2907 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2535 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5804 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1676 | 0.020 |
Why?
|
Exons | 1 | 2013 | 2394 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1890 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2810 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3683 | 0.020 |
Why?
|
Acrosome Reaction | 1 | 2007 | 7 | 0.020 |
Why?
|
Sperm Head | 1 | 2007 | 8 | 0.020 |
Why?
|
Litter Size | 1 | 2007 | 49 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 2001 | 13422 | 0.020 |
Why?
|
Vinblastine | 2 | 1998 | 487 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3670 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23782 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3620 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2007 | 260 | 0.020 |
Why?
|
Risk Factors | 2 | 2012 | 74944 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2006 | 138 | 0.020 |
Why?
|
Interphase | 1 | 2006 | 227 | 0.020 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2006 | 152 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3567 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5926 | 0.020 |
Why?
|
Dacarbazine | 2 | 1998 | 552 | 0.020 |
Why?
|
Threonine | 1 | 2006 | 273 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6231 | 0.020 |
Why?
|
HeLa Cells | 2 | 2001 | 3074 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2011 | 1273 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 669 | 0.010 |
Why?
|
Cricetulus | 1 | 2006 | 812 | 0.010 |
Why?
|
Luciferases | 1 | 2006 | 713 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6395 | 0.010 |
Why?
|
Cell Communication | 1 | 2011 | 1660 | 0.010 |
Why?
|
Telomerase | 1 | 2008 | 751 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2003 | 210 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 6019 | 0.010 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2003 | 178 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 253 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 250 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39354 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 30009 | 0.010 |
Why?
|
Aneuploidy | 1 | 2006 | 573 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2002 | 270 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2065 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 866 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6525 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10101 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2001 | 6512 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 362 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5902 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 943 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2002 | 855 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1089 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7213 | 0.010 |
Why?
|
Czech Republic | 1 | 1998 | 75 | 0.010 |
Why?
|
Filgrastim | 1 | 1998 | 131 | 0.010 |
Why?
|
Caspase 3 | 1 | 2001 | 730 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10266 | 0.010 |
Why?
|
Austria | 1 | 1998 | 208 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1683 | 0.010 |
Why?
|
Brain | 2 | 2022 | 27362 | 0.010 |
Why?
|
Switzerland | 1 | 1998 | 323 | 0.010 |
Why?
|
Caspases | 1 | 2001 | 882 | 0.010 |
Why?
|
Leukemia | 2 | 1998 | 1519 | 0.010 |
Why?
|
Xenopus | 1 | 1999 | 711 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 1999 | 564 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2001 | 1743 | 0.010 |
Why?
|
Cadherins | 1 | 2001 | 905 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 16044 | 0.010 |
Why?
|
Germany | 1 | 1998 | 883 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1998 | 631 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1999 | 1751 | 0.010 |
Why?
|
Protein Transport | 1 | 2001 | 1951 | 0.010 |
Why?
|
Prostatectomy | 1 | 2003 | 1786 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3590 | 0.010 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1994 | 74 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5213 | 0.010 |
Why?
|
Thionucleotides | 1 | 1994 | 107 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1994 | 195 | 0.010 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1994 | 94 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1994 | 351 | 0.010 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1994 | 186 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6330 | 0.010 |
Why?
|
Guanosine Diphosphate | 1 | 1993 | 79 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1994 | 1142 | 0.010 |
Why?
|
Remission Induction | 1 | 1998 | 2410 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 1993 | 225 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2885 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 1994 | 657 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 826 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1989 | 5196 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1061 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1999 | 2451 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1998 | 4861 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1993 | 2748 | 0.000 |
Why?
|
Cytarabine | 1 | 1989 | 695 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4168 | 0.000 |
Why?
|
Cattle | 1 | 1993 | 3819 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9016 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1998 | 8542 | 0.000 |
Why?
|
United States | 1 | 2012 | 73039 | 0.000 |
Why?
|
Antigens, CD | 1 | 1994 | 4035 | 0.000 |
Why?
|
Dexamethasone | 1 | 1989 | 1965 | 0.000 |
Why?
|
Cohort Studies | 1 | 2003 | 41753 | 0.000 |
Why?
|
Disease Progression | 1 | 1998 | 13668 | 0.000 |
Why?
|